Overview
Shil focuses his practice on healthcare, with a particular emphasis on transactional and regulatory matters. He is committed to helping healthcare providers navigate the complex legal landscape with a client-centered approach.
Shil’s legal experience includes research on healthcare regulations and compliance, as well as transactional matters related to the industry. He values collaboration and believes that working with a connected, supportive team enhances both the client experience and the quality of legal solutions.
Before joining Benesch, Shil gained valuable experience as a consultant and project manager, developing strong time management and project coordination skills that now inform his legal practice. Known for his strong work ethic and interpersonal skills, Shil is dedicated to further developing his practice in the healthcare sector by achieving meaningful results for his clients.
What I Do
Credentials
Education
- Order of Omega
- Cum Laude
- Dean’s List
- Rickert Award Winner for Service
- Managing Editor, Journal of Law, Technology & Policy
- Leadership Scholar
Bar & Court Admissions
Related News & Insights
Law.com Highlights Benesch Analysis of HRSA’s Revised 340B Rebate Pilot
A recent Law.com article examining the Health Resources and Services Administration’s revised 340B Rebate Model Pilot Program cited analysis from …
HRSA’s Revised 340B Rebate Pilot Drama
The Health Resources and Services Administration’s revised 340B Rebate Model Pilot would replace up-front discounts with post-purchase rebates for 21 drugs beginning January 1, 2027, requiring covered entities to pay full wholesale acquisition cost and submit claims data to recover the 340B discount.
Benesch Advises Preferred Vascular Group in Strategic Sale to Surgery Partners
Benesch is pleased to announce that it served as legal counsel to Preferred Vascular Group (PVG) in its recent acquisition …
CMS Issues a Nationwide Moratorium on New Medicare Enrollment of Some DMEPOS Suppliers
CMS has imposed a six‑month nationwide moratorium beginning February 27, 2026, that blocks new Medicare enrollments for certain DMEPOS suppliers as part of its CRUSH initiative.